Scilex Holding Company (NASDAQ:SCLX)’s traded shares stood at 3.22 million during the last session, with the company’s beta value hitting 1.07. At the close of trading, the stock’s price was $0.47, to imply an increase of 5.25% or $0.02 in intraday trading. The SCLX share’s 52-week high remains $2.63, putting it -459.57% down since that peak but still an impressive 19.15% since price per share fell to its 52-week low of $0.38. The company has a valuation of $112.21M, with an average of 1.16 million shares in intraday trading volume over the past 10 days and average of 2.22 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Scilex Holding Company (SCLX), translating to a mean rating of 1.00. Of 2 analyst(s) looking at the stock, 0 analyst(s) give SCLX a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 2 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.1.
Scilex Holding Company (NASDAQ:SCLX) trade information
After registering a 5.25% upside in the last session, Scilex Holding Company (SCLX) has traded red over the past five days. The 5-day price performance for the stock is 3.67%, and -7.55% over 30 days. With these gigs, the year-to-date price performance is 10.04%. Short interest in Scilex Holding Company (NASDAQ:SCLX) saw shorts transact 4.91 million shares and set a 3.25 days time to cover.
Scilex Holding Company (SCLX) estimates and forecasts
Looking at statistics comparing Scilex Holding Company share performance against respective industry, we note that the company has outperformed competitors. Scilex Holding Company (SCLX) shares are -75.94% down over the last 6 months, with its year-to-date growth rate higher than industry average at 28.23% against 16.70%. The rating firms project that company’s revenue will grow 30.34% compared to the previous financial year.
Revenue forecast for the current quarter as set by 3 analysts is 15.7M. Meanwhile, for the current quarter, a total of 3 analyst(s) estimate revenue growth to 18.04M.Earnings reports from the last fiscal year show that sales brought in 10.12M and 13.46M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 55.20% before jumping 34.00% in the following quarter.
SCLX Dividends
Scilex Holding Company has its next earnings report out in February. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Scilex Holding Company (NASDAQ:SCLX)’s Major holders
Scilex Holding Company insiders hold 24.22% of total outstanding shares, with institutional holders owning 14.47% of the shares at 19.09% float percentage. In total, 14.47% institutions holds shares in the company.
We also have SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF and Vanguard Total Stock Market Index Fund as the top two Mutual Funds with the largest holdings of the Scilex Holding Company (SCLX) shares. Going by data provided on Oct 31, 2024 , SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF holds roughly 5.94 shares. This is just over 3.10% of the total shares, with a market valuation of $2.79 million. Data from the same date shows that the other fund manager holds a little less at 3.71, or 1.94% of the shares, all valued at about 1.74 million.
